Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nuvigil for Postoperative Recovery in OSA and Obese Patients
NCT02478580Phase 3Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Aug 2011
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of armodafinil in delayed recovery from anesthesia, sponsored by UT Southwestern Medical Center. Primary endpoint: Postoperative Care Unit Recovery Time at 3 hours. Started Aug 2011; status: completed.
02
Drugs
armodafinil
03
Conditions
delayed recovery from anesthesia
Beyond the preview
Go deeper on NCT02478580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478580.